AR009231A1 - Formulaciones en aerosol de formoterol. - Google Patents

Formulaciones en aerosol de formoterol.

Info

Publication number
AR009231A1
AR009231A1 ARP970102437A ARP970102437A AR009231A1 AR 009231 A1 AR009231 A1 AR 009231A1 AR P970102437 A ARP970102437 A AR P970102437A AR P970102437 A ARP970102437 A AR P970102437A AR 009231 A1 AR009231 A1 AR 009231A1
Authority
AR
Argentina
Prior art keywords
hfa
drug
aerosol formulations
formoterol
hfa13
Prior art date
Application number
ARP970102437A
Other languages
English (en)
Spanish (es)
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10795182&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR009231(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of AR009231A1 publication Critical patent/AR009231A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP970102437A 1996-06-11 1997-06-04 Formulaciones en aerosol de formoterol. AR009231A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612297.3A GB9612297D0 (en) 1996-06-11 1996-06-11 Medicinal aerosol formulations

Publications (1)

Publication Number Publication Date
AR009231A1 true AR009231A1 (es) 2000-04-12

Family

ID=10795182

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970102437A AR009231A1 (es) 1996-06-11 1997-06-04 Formulaciones en aerosol de formoterol.

Country Status (16)

Country Link
EP (2) EP1400239A1 (enExample)
JP (1) JP5000793B2 (enExample)
AR (1) AR009231A1 (enExample)
AT (1) ATE275940T1 (enExample)
AU (1) AU726382B2 (enExample)
CA (1) CA2257841C (enExample)
DE (1) DE69730723T2 (enExample)
DK (1) DK0934057T3 (enExample)
ES (1) ES2229366T3 (enExample)
GB (1) GB9612297D0 (enExample)
ID (1) ID19520A (enExample)
NO (1) NO320403B1 (enExample)
NZ (1) NZ333202A (enExample)
PT (1) PT934057E (enExample)
WO (1) WO1997047286A1 (enExample)
ZA (1) ZA974546B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
ES2178479T3 (es) * 1998-10-17 2002-12-16 Boehringer Ingelheim Pharma Concentrado de principio activo con formoterol, apto para el almacenamiento.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
UA73986C2 (uk) 2000-05-22 2005-10-17 К'Єзі Фармачеутічі С.П.А. АЕРОЗОЛЬНА КОМПОЗИЦІЯ, ЩО МІСТИТЬ <font face="Symbol">b</font>2-АДРЕНЕРГІЧНИЙ АГОНІСТ ТРИВАЛОЇ ДІЇ, ДОЗУЮЧИЙ ІНГАЛЯТОР ПІД ТИСКОМ ТА СПОСІБ ЙОГО ЗАПОВНЕННЯ
SE0004750D0 (sv) 2000-12-19 2000-12-19 Astrazeneca Ab Novel formulation
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
ES2222294T3 (es) 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Formulacion optimizada de tobramicina para administracion en forma de aerosol.
TWI324934B (en) * 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
AU2003265639A1 (en) * 2002-08-27 2004-03-19 Schering Corporation Process for producing metered dose inhaler formulations
CA2528479A1 (en) * 2003-06-13 2004-12-23 Altana Pharma Ag Formoterol and ciclesonide combination
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
AU2004285447A1 (en) * 2003-10-20 2005-05-12 Schering Corporation Pharmaceutical compositions
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
ES2398480T3 (es) * 2006-10-17 2013-03-19 Lithera, Inc. Procedimientos, composiciones, y formulaciones para el tratamiento de la enfermedad ocular tiroidea
SMT202000077T1 (it) 2009-05-29 2020-03-13 Pearl Therapeutics Inc Composizioni per il rilascio polmonare di antagonisti muscarinici a lunga durata e agonisti dei recettori beta-2 adrenergici a lunga durata e metodi e sistemi associati
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
DK2482799T3 (da) * 2009-10-02 2014-09-01 Chiesi Farma Spa Farmaceutiske aerosolformuleringer af formoterol og beclometasondipropionat
MX361286B (es) 2013-03-15 2018-12-03 Pearl Therapeutics Inc Métodos y sistemas para el acondicionamiento de materiales cristalinos de partículas.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05508616A (ja) * 1989-02-23 1993-12-02 ローヌー　プーラン　ローラー　インターナショナル（ホウルディングス）インコーポレイテッド 治療用エアロゾル剤
IE67185B1 (en) * 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
WO1992022288A1 (en) * 1991-06-10 1992-12-23 Schering Corporation Non-chlorofluorocarbon aerosol formulations
AU2178992A (en) * 1991-06-10 1993-01-12 Schering Corporation Non-chlorofluorocarbon aerosol formulations
CA2125665C (en) * 1991-12-12 2001-06-12 Rachel Ann Akehurst Medicaments
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
DK0617610T3 (da) * 1991-12-18 1997-10-06 Minnesota Mining & Mfg Suspensionsaerosolformuleringer.
GB9207400D0 (en) * 1992-04-02 1992-05-13 Smithkline Beecham Plc Novel use
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
NZ333202A (en) 2000-06-23
EP0934057A1 (en) 1999-08-11
JP5000793B2 (ja) 2012-08-15
PT934057E (pt) 2004-12-31
DE69730723T2 (de) 2005-10-06
ID19520A (id) 1998-07-16
EP0934057B1 (en) 2004-09-15
DK0934057T3 (da) 2005-01-24
CA2257841C (en) 2008-05-20
AU3373997A (en) 1998-01-07
NO985720L (no) 1999-02-11
ZA974546B (en) 1998-11-23
NO320403B1 (no) 2005-11-28
GB9612297D0 (en) 1996-08-14
JP2000513340A (ja) 2000-10-10
CA2257841A1 (en) 1997-12-18
DE69730723D1 (de) 2004-10-21
ES2229366T3 (es) 2005-04-16
WO1997047286A1 (en) 1997-12-18
EP1400239A1 (en) 2004-03-24
NO985720D0 (no) 1998-12-07
ATE275940T1 (de) 2004-10-15
AU726382B2 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
AR009231A1 (es) Formulaciones en aerosol de formoterol.
DK0616525T3 (da) Medikamenter
BG102689A (bg) Фармацевтичен аерозолен състав за използване при лечение на респираторни смущения
ES2106360T3 (es) Formulaciones farmaceuticas de aerosol que contienen dipropionato de beclometasona.
ES2093735T3 (es) Derivados de melatonina para uso en la terapia de trastornos del sueño y en medicacion preanestesica.
BR9916865A (pt) Composição farmacêutica em aerossol contendohfa 227 e hfa 134a
ES2123576T3 (es) Medicamentos.
DK0656207T3 (da) Aerosolformuleringer uden chlorfluorcarbonforbindelser
AR011080A1 (es) Composicion en polvo seco, proceso para su preparacion y uso de dicha composicion para la fabricacion del medicamento
ES2193186T3 (es) Composiciones medicamentosas en aerosol para la utilizacion con gases propulsores sin cfc.
DK0500594T3 (da) Lægemiddelsammensætninger indeholdende små partikler
AR018891A1 (es) Inhaladores presurizados de dosificacion medida y formulaciones farmaceuticas en aerosol
HU226694B1 (en) Medicinal aerosol products containing ciclesonide
ES2134634T3 (es) Composiciones farmaceuticas y dispositivos para su administracion.
ATE137958T1 (de) Pharmazeutische aerosolzubereitung sowie deren verwendung zur behandlung und prophylaxe viraler erkrankungen
BG107257A (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
ES2171459T3 (es) Polvo para administracion nasal de farmaco peptidico o proteinaceo.
FI962056A0 (fi) Uusi farmaseuttinen koostumus stabiilin jauheen valmistamiseksi, joka sisältää asetyylisalisyylihapon ja metoklopramidin yhdistelmän käsittävän aktiivisen aineosan
US2802772A (en) Aerosols compositions; bomb, and process for treating flocks of chickens
Gunther et al. Inhibition of the catalyzed thermal decomposition of DDT
NZ231822A (en) Pharmaceutical aerosol formulation of sodium cromoglycate with chlorofluorocarbon propellant
BR0010449A (pt) 14beta-h-esteróis, composições farmacêuticas que compreendem os mesmos e uso destes derivados para a preparação de medicamentos reguladores da meiose
BR9805026A (pt) Compostos contdndo tetrahidrolipstatina